{"name":"Owkin","slug":"owkin","ticker":"PRIVATE","exchange":"Private","domain":"owkin.com","description":"Owkin is a French-American artificial intelligence and biotech company that aims to identify new treatments, optimize clinical trials and develop AI diagnostics. The company uses multimodal patient data from academic institutions and hospitals to train its AI models for drug discovery, development, and diagnostics. Owkin has collaborated with pharmaceutical companies around the world to improve their therapeutic programs.","hq":"Paris, France / New York, NY","founded":0,"employees":"","ceo":"Thomas Clozel","sector":"AI Drug Development / Precision Medicine","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"$1.1B (last private valuation)","metrics":{"revenue":30000000,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2024-02-15","type":"deal","headline":"Owkin Partners with Pfizer to Develop AI-Powered Cancer Therapies","summary":"Owkin announced a strategic partnership with Pfizer to develop and commercialize AI-powered cancer therapies.","drugName":"","sentiment":"positive"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxPUFdOMVhqQkNsMWZCQmZsbG5NT2RzaGZmY2hNbTJscU5SOWhjNV9HMlA1STVXbHZodnVKNkdRMVV0N3Y5d0pyVGdLQlNUNHdQR214TF8wNGF1cGMxRUFRTVpRbHNuZDZEUUQwVUtXcVI0UURVdHhJZ0xUYld5aTVKemNSVE1UOVk1MWxTbHlxSDdsUXU2YV84QjNyb1QzUWhSM0tONEtjbTRfYmFhUE9fZFhHVXZSUFFsNEVpaHlobkw?oc=5","date":"2026-04-02","type":"pipeline","source":"TipRanks","summary":"OWKIN Highlights AI-Agent Approach to Accelerate Drug Discovery Experiments - TipRanks","headline":"OWKIN Highlights AI-Agent Approach to Accelerate Drug Discovery Experiments","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxQTmFrQWg1cFBGUnQtbmtya21rOURfT2ktUDI5cFdDTVVfZmxMR2FWVGxyNlRhQ1B6ZGtGWTVBZnBwcWY3QWU2aGhxcmtwa1NQUUxsV2xyRUEzdVc5YjBGbF85UndBNTB4bWdkUWdwM0tmNU1EOXYzZFNBYnJfWm1qbDJzb2Z1N2txY3ZYeFZycEFsY1lSa244QTdWVTdCTnVtZWdVQzlYdkpJcFN3THB1RTNJbTZTSElZ?oc=5","date":"2026-03-31","type":"pipeline","source":"TipRanks","summary":"OWKIN Showcases AI-Driven Oncology R&D Capabilities Ahead of AACR 2026 - TipRanks","headline":"OWKIN Showcases AI-Driven Oncology R&D Capabilities Ahead of AACR 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxNVWNGTG9zaHZDTG9RbEJoQ1E5TldqRE9mWG1XbDV1aENPMGlRUHlpbjdjNW5Za2lxcnFFT3g4dTNZTHNLRkRGclB3QnNnOC1SQjNrQUhOVVhFVlE0ZUI2MkZTcklCOVFtbHN6dVFNdk9aNm5GdG1hZFVvRjNfbElHdmV6dzR6RWVOQzlVX1phbw?oc=5","date":"2023-08-21","type":"pipeline","source":"drugdiscoverytrends.com","summary":"Techbio landscape: Insights into AI and genomics in pharma - drugdiscoverytrends.com","headline":"Techbio landscape: Insights into AI and genomics in pharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxOVVhsV0hGTnZVLVlfQ18tSHUtMXIwdXlDY0VCdlNxQVBnX1J5dFIzb0JGTGpIOS0yNDlHa0NmVDVYLU85dXF4eVpCRXBVRFVtZ1BfSXN4WEJPMkJVeVFHWTI2VlBFajByZlo0UXZHNjY5SExkbjN1cHdqOGduWXk4M2swZWo0QQ?oc=5","date":"2023-06-23","type":"deal","source":"Pharma Voice","summary":"How Sanofi is taking a ‘creative’ approach to dealmaking - Pharma Voice","headline":"How Sanofi is taking a ‘creative’ approach to dealmaking","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9gFBVV95cUxOeW82MFBLMkU4WEVmUUJyUFhQbDdpR1ozYnBYam90eGZTaTdwUDM3ckNxQUp1ZHRqZEJpMDN4WllJWmJLdGM4dlFJNFlvemdrM3VqOXlMWWtSSDlFM0JaZHR6RUE4OTEydnUzQno2OE1sbkpLMFlYRU5MNmpTemllNWVBTm1LOHd3dWFIc3pJbDdaakd2am9IN282QUU5bFdFNzBKcWdBSzN2UGxQMjJNY1hZYXVHRlg5ZldaSnhWNDM1cUJ6cnZUcmVTUzJRWmdlWDR1Q21oNjhMM2xFaVhYMng2dzdwa0RNeWZuNjRnM0lrNzdmeHc?oc=5","date":"2021-06-01","type":"deal","source":"PR Newswire","summary":"Owkin Bolsters Senior Team With Experienced Pharma Executives to Expand Platform and Strategic Partnerships - PR Newswire","headline":"Owkin Bolsters Senior Team With Experienced Pharma Executives to Expand Platform and Strategic Partnerships","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["DeepMind","IBM Watson Health","Google Life Sciences"],"therapeuticFocus":["Oncology","Immunology"],"financials":null,"yahoo":null}